Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEMOIR trial in chronic complex regional pain syndrome
ACTRN12621000175875Phase 3Recruiting
- Sponsor
- Neuroscience Research Australia
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of memantine in complex regional pain syndrome (CRPS), sponsored by Neuroscience Research Australia. Started May 2021; status: recruiting.
02
Drugs
memantine
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on ACTRN12621000175875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000175875.